Clofarabine in High Risk Myelodysplastic Syndrome (MDS)
Clinical trial NCT01063257 · COMPLETED
Trial details
- NCT number
- NCT01063257
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2014-03-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.